Daily Newsletter

14 August 2023

Share with colleague
Subscribe

Daily Newsletter

14 August 2023

Share with colleague
Subscribe

Spotlight

Exor snaps up 15% stake in Philips for around $2.8bn

Italy’s billionaire Agnelli family has added the healthcare giant to its portfolio that includes Ferrari and Juventus Football Club.

Latest news

Scottish Brain Sciences and Roche work on Alzheimer’s blood test development

By utilising blood-based biomarkers, the entities aim to offer a deeper understanding of the initial biological alterations in neurodegenerative diseases.

14 August 2023

Xeltis concludes D2 financing with additional €12.5m from EIC Fund

The latest funding will help advance the ongoing clinical development of the company's implants.

14 August 2023

ReWalk Robotics concludes acquisition of AlterG

Charles Remsberg, who formerly served as CEO of AlterG, has taken on the role of chief sales officer at ReWalk.

14 August 2023

Further clinical success for Anteris Technologies’ biomimetic heart valve

A second valve-in-valve case adds to two early feasibility studies being conducted in the US and Europe for the device.

14 August 2023

Nemaura Medical receives $6.5m in non-dilutive financing

Nemaura is presently conducting research alongside the UK's NHS, focusing on its metabolic health programme.

14 August 2023

TriSalus merges with MedTech Acquisition to bolster cash reserves

TriSalus is breaking into immuno-oncology area with its TLR agonist SD-101 for treating solid tumours.

14 August 2023

FDA approves smaller height of Mobi-C artificial discs for cervical replacement

The newly approved 4.5mm artificial discs will give surgeons more flexibility in choosing the implant of best fit for patients.

14 August 2023

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.